Interdict Bio
Interdict | Home
San Francisco, United States · $26.5M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- interdictbio.com
- Total Funding
- $26.5M
- Last Round
- $17.5M Series ASep 2025
- Rounds
- 2
About
Developer of small molecule Interdictor therapeutics that inhibit ribosomal protein synthesis to address historically undruggable targets.
Summary
Interdict Bio is a Biotech company based in San Francisco, United States. It has raised $26.5M in total across 2 rounds, most recently a $17.5M Series A round in Sep 2025. Investors include Altitude Life Science Ventures, Mission Bay Capital and Venrock.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company